Florence Le Maulf
Reims, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease.
Journal: BMJ open respiratory research
Published: May 09, 2017
Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria.
Journal: American journal of respiratory and critical care medicine
Published: June 23, 2016
Reply: Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?
Journal: American journal of respiratory and critical care medicine
Published: October 16, 2015
Tiotropium Respimat in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 30, 2014
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Journal: The New England journal of medicine
Published: May 20, 2014
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
Journal: Circulation
Published: December 18, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026